A novel formulation of the muscle relaxant drug cyclobenzaprine has won FDA approval for treating fibromyalgia, manufacturer Tonix Pharmaceuticals announced on Friday. To be sold as Tonmya, the ...
In August 2025, the US Food and Drug Administration (FDA) approved Tonmya ® (cyclobenzaprine hydrochloride sublingual tablets; Tonix Pharmaceuticals) for the treatment of fibromyalgia in adults. Study ...
TNX-102 SL is a non-opioid, centrally-acting analgesic administered at bedtime for the treatment of fibromyalgia. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ...
“TNX-102 SL, Cyclobenzaprine HCl Sublingual Tablets, Demonstrates Pain Reduction and Favorable Tolerability in Participants With Fibromyalgia” “Sublingual Cyclobenzaprine (TNX-102 SL) for Fibromyalgia ...
Credit: Tonix Pharmaceuticals. Tonmya is a once-daily sublingual tablet of cyclobenzaprine HCI taken at bedtime for the treatment of fibromyalgia. Clinical trials have demonstrated that Tonmya reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback